Abstract:Background Mitochondrial dysfunction is one of the hallmarks of aging and a leading contributor to sarcopenia. Nutrients are essential for improving mitochondrial function and skeletal muscle health during the aging process. Betaine is a nutrient with potential muscle‐preserving properties. However, whether and how betaine could regulate the mitochondria function in aging muscle are poorly understood. We aimed to explore the molecular target and underlying mechanism of betaine in attenuating the age‐related mitochondrial dysfunction in skeletal muscle. Methods Young mice (YOU, 2 months), old mice (OLD, 15 months), and old mice with betaine treatment (BET, 15 months) were fed for 12 weeks. The effects of betaine on muscle mass, strength, function, and subcellular structure of muscle fibres were assessed. RNA sequencing (RNA‐seq) was conducted to identify the molecular target of betaine. The impacts of betaine on mitochondrial‐related molecules, superoxide accumulation, and oxidative respiration were examined using western blotting (WB), immunofluorescence (IF) and seahorse assay. The underlying mechanism of betaine regulation on the molecular target to maintain mitochondrial function was investigated by luciferase reporter assay, chromatin immunoprecipitation and electrophoretic mobility shift assay. Adenoassociated virus transfection, succinate dehydrogenase staining (SDH), and energy expenditure assessment were performed on 20‐month‐old mice for validating the mechanism in vivo. Results Betaine intervention demonstrated anti‐aging effects on the muscle mass (P = 0.017), strength (P = 0.010), and running distance (P = 0.013). Mitochondrial‐related markers (ATP5a, Sdha, and Uqcrc2) were 1.1‐ to 1.5‐fold higher in BET than OLD (all P ≤ 0.036) with less wasted mitochondrial vacuoles accumulating in sarcomere. Bioinformatic analysis from RNA‐seq displayed pathways related to mitochondrial respiration activity was higher enriched in BET group (NES = −0.87, FDR = 0.10). The quantitative real time PCR (qRT‐PCR) revealed betaine significantly reduced the expression of a novel mitochondrial regulator, Mss51 (−24.9%, P = 0.002). In C2C12 cells, betaine restored the Mss51‐mediated suppression in mitochondrial respiration proteins (all P ≤ 0.041), attenuated oxygen consumption impairment, and superoxide accumulation (by 20.7%, P = 0.001). Mechanically, betaine attenuated aging‐induced repression in Yy1 mRNA expression (BET vs. OLD: 2.06 vs. 1.02, P = 0.009). Yy1 transcriptionally suppressed Mss51 mRNA expression both in vitro and in vivo. This contributed to the preservation of mitochondrial respiration, improvement for energy expenditure (P = 0.008), and delay of muscle loss during aging process. Conclusions Altogether, betaine transcriptionally represses Mss51 via Yy1, improving age‐related mitochondrial respiration in skeletal muscle. These findings suggest betaine holds promise as a dietary supplement to delay skeletal muscle degeneration and improve age‐related mitochondrial diseases.

Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging

Targeting Mitochondrial Quality Control in Muscle Aging: Natural Dietary Products As Potential Interventions

The effect of short-term methionine restriction on hydrogen peroxide metabolism in Fischer-344 rat skeletal muscle mitochondria

The Potentials of Methylene Blue as an Anti-Aging Drug

Betaine delays age‐related muscle loss by mitigating Mss51‐induced impairment in mitochondrial respiration via Yin Yang1

Enhancing healthy aging with small molecules: A mitochondrial perspective

The Potential of Mitochondrial Therapeutics in the Treatment of Oxidative Stress and Inflammation in Aging

Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats

Oral subchronic toxicity study and genetic toxicity evaluation of mitoquinone mesylate

Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle

Delaying Brain Mitochondrial Decay and Aging with Mitochondrial Antioxidants and Metabolites

Protective effect of MitoQ on oxidative stress-mediated senescence of canine bone marrow mesenchymal stem cells via activation of the Nrf2/ARE pathway

Targeting Multiple Mitochondrial Processes by a Metabolic Modulator Prevents Sarcopenia and Cognitive Decline in SAMP8 Mice

Mitochondrial Transplantation's Role in Rodent Skeletal Muscle Bioenergetics: Recharging the Engine of Aging

Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing

Targeting organ-specific mitochondrial dysfunction to improve biological aging

Investigating impacts of the mycothiazole chemotype as a chemical probe for the study of mitochondrial function and aging

Myricanol prevents aging-related sarcopenia by rescuing mitochondrial dysfunction via targeting peroxiredoxin 5

Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice

The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice

Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20